Familial Lung Adenocarcinoma Caused by the EGFR V843I Germ-Line Mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Familial Lung Adenocarcinoma Caused by the EGFR V843I Germ-Line Mutation

Published:2011-03-10 Issue:8 Volume:29 Page:e191-e192
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ohtsuka Kouki¹,Ohnishi Hiroaki¹,Kurai Daisuke¹,Matsushima Satsuki¹,Morishita Yukio²,Shinonaga Mayumi³,Goto Hajime¹,Watanabe Takashi⁴

Affiliation:

1. Kyorin University School of Medicine, Tokyo, Japan

2. Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan

3. Mito Saiseikai General Hospital, Ibaraki, Japan

4. Kyorin University School of Medicine; Kyorin University Hospital, Tokyo, Japan

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.31.4492

Reference8 articles.

1. EGFRMutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

3. Novel Germline Mutation: EGFR V843I in Patient With Multiple Lung Adenocarcinomas and Family Members With Lung Cancer

4. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR

5. Germ-Line and Somatic Presentations of the EGFR T790M Mutation in Lung Cancer

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations;Hereditary Cancer in Clinical Practice;2024-08-19

2. Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations;Journal of Thoracic Oncology;2024-06

3. Lung cancer in patients who have never smoked — an emerging disease;Nature Reviews Clinical Oncology;2024-01-09

4. The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality;Journal of Thoracic Oncology;2023-09

5. Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer;Lung Cancer;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3